Osteoporosis

Osteoporosis and its management.
[17170416] BMJ 333(7581): 1251-6 (2006)

Osteoporosis: epidemiology, diagnosis, and treatment.
[10653058] South Med J 93(1): 2-18 (2000)

Managing osteoporosis: challenges and strategies.
[19652039] Cleve Clin J Med 76(8): 457-66 (2009)

Using biochemical markers of bone turnover in clinical practice.
[18939390] Cleve Clin J Med 75(10): 739-50 (2008)

Clinical challenges in the management of osteoporosis.
[18686753] Clin Interv Aging 3(2): 315-29 (2008)

Teriparatide in the management of osteoporosis.
[18225450] Clin Interv Aging 2(4): 499-507 (2007)

Diagnostic challenges in osteoporosis. Indications for bone densitometry and establishing secondary causes.
[11421053] Can Fam Physician 47(-): 1244-50 (2001)

The diagnosis and treatment of primary osteoporosis according to current guidelines.
[19471676] Dtsch Arztebl Int 105(33): 573-81; quiz 581-2 (2008)

Odanacatib, a new drug for the treatment of osteoporosis: review of the results in postmenopausal women.
[20948576] J Osteoporos 2010(-): - (2010)

Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis.
[19898646] Ther Clin Risk Manag 5(-): 817-27 (2009)

Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.
[17311734] Health Technol Assess 11(7): iii-iv, ix-xi, 1-231 (2007)

A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.
[15929857] Health Technol Assess 9(22): 1-160 (2005)

Treatment of established osteoporosis: a systematic review and cost-utility analysis.
[12654239] Health Technol Assess 6(29): 1-146 (2002)

Lasofoxifene: Evidence of its therapeutic value in osteoporosis.
[20694069] Core Evid 4(-): 113-29 (2010)

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect.
[20694061] Core Evid 4(-): 13-23 (2010)

Developments in the scientific understanding of osteoporosis.
[19497136] Arthritis Res Ther 11(3): 228 (2009)

The management of osteoporosis.
[11341411] J Bone Joint Surg Br 83(3): 316-23 (2001)

Osteopenia and cancer in children and adolescents: the fragility of success.
[17326055] Cancer 109(7): 1420-31 (2007)

Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
[18305064] Oncologist 13(2): 187-95 (2008)

Bone loss and fracture risk associated with cancer therapy.
[17110632] Oncologist 11(10): 1121-31 (2006)

Parathyroid hormone and teriparatide for the treatment of osteoporosis: a review of the evidence and suggested guidelines for its use.
[15769903] Endocr Rev 26(5): 688-703 (2005)

Biochemical markers of bone turnover: part I: biochemistry and variability.
[16648882] Clin Biochem Rev 26(4): 97-122 (2005)

An integrated approach: bisphosphonate management for the treatment of osteoporosis.
[18095779] Am J Manag Care 13 Suppl 11(-): S290-308; quiz S309-12 (2007)

Medical management of osteoporosis.
[15298366] Am J Manag Care 10(7 Pt 1): 445-55 (2004)

Evaluation and treatment of postmenopausal osteoporosis.
[11599675] Am J Manag Care 7 Spec No(-): SP5-16 (2001)

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis.
[11465699] Arthritis Rheum 44(7): 1496-503 (2001)

The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach.
[10446876] Arthritis Rheum 42(8): 1740-51 (1999)

Management of osteoporosis in children.
[18772270] Eur J Endocrinol 159 Suppl 1(-): S33-9 (2008)

Glucocorticoid osteoporosis--mechanisms and management.
[9330580] Eur J Endocrinol 137(3): 209-17 (1997)

Guidelines for osteoporosis in coeliac disease and inflammatory bowel disease. British Society of Gastroenterology.
[10647595] Gut 46 Suppl 1(-): i1-8 (2000)

Pathogenesis of osteoporosis: concepts, conflicts, and prospects.
[16322775] J Clin Invest 115(12): 3318-25 (2005)

Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem.
[11241167] J Endocrinol 168(3): 353-62 (2001)

Combined therapies in osteoporosis: bisphosphonates and vitamin D-hormone analogs.
[17627088] J Musculoskelet Neuronal Interact 7(2): 174-84 (2007)

Clinical use of bone densitometry: clinical applications.
[12377089] JAMA 288(15): 1898-900 (2002)

Clinical use of bone densitometry: scientific review.
[12377088] JAMA 288(15): 1889-97 (2002)

Diagnosis, screening, prevention, and treatment of osteoporosis.
[16706264] Mayo Clin Proc 81(5): 662-72 (2006)

Secondary causes of osteoporosis.
[12004995] Mayo Clin Proc 77(5): 453-68 (2002)

Osteoporosis prophylaxis during corticosteroid treatment: failure to prescribe.
[11930029] Postgrad Med J 78(918): 242-3 (2002)

Management of corticosteroid-induced osteoporosis.
[12364625] Rheumatology (Oxford) 41(10): 1088-94 (2002)

Understanding osteoporosis.
[1877231] West J Med 155(1): 53-60 (1991)

Overview of osteoporosis.
[2024511] West J Med 154(1): 63-77 (1991)

Osteoporosis in celiac disease and in endocrine and reproductive disorders.
[18203279] World J Gastroenterol 14(4): 498-505 (2008)

Basic and clinical aspects of osteoporosis in inflammatory bowel disease.
[18069754] World J Gastroenterol 13(46): 6156-65 (2007)

Parathyroid hormone for the treatment of osteoporosis: a systematic review.
[16818910] CMAJ 175(1): 52-9 (2006)

Clinical practice guidelines for the use of parathyroid hormone in the treatment of osteoporosis.
[16818909] CMAJ 175(1): 48 (2006)

High-resolution imaging techniques for the assessment of osteoporosis.
[20609895] Radiol Clin North Am 48(3): 601-21 (2010)

The genetics of osteoporosis.
[17940498] Acta Reumatol Port 32(3): 231-40 (2007)

Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.
[17604458] Altern Med Rev 12(2): 113-45 (2007)

How to prevent glucocorticoid-induced osteoporosis.
[20682515] Cleve Clin J Med 77(8): 529-36 (2010)

Biochemical markers of bone turnover: useful but underused.
[18939391] Cleve Clin J Med 75(10): 751-2 (2008)

Osteoporosis - new treatments and updates.
[20969546] Bull NYU Hosp Jt Dis 68(3): 166-70 (2010)

Treatment strategies for patients with low bone mass: the younger postmenopausal female.
[18937639] Bull NYU Hosp Jt Dis 66(3): 240-3 (2008)

Update on medications with adverse skeletal effects.
[21389249] Mayo Clin Proc 86(4): 338-43; quiz 343 (2011)

Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases.
[15136401] Chest 125(5): 1859-76 (2004)

Comparing pain reduction following kyphoplasty and vertebroplasty for osteoporotic vertebral compression fractures.
[17660858] Pain Physician 10(4): 583-90 (2007)

Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence.
[12213840] J Clin Endocrinol Metab 87(9): 4033-41 (2002)

Long-term use of bisphosphonates in osteoporosis.
[20173017] J Clin Endocrinol Metab 95(4): 1555-65 (2010)

Approach to the patient with secondary osteoporosis.
[20231368] Eur J Endocrinol 162(6): 1009-20 (2010)

Osteoblasts in osteoporosis: past, emerging, and future anabolic targets.
[21543379] Eur J Endocrinol 165(1): 1-10 (2011)

Genetics of osteoporosis.
[20431112] Endocr Rev 31(5): 629-62 (2010)

Myeloma bone disease and proteasome inhibition therapies.
[17494860] Blood 110(4): 1098-104 (2007)

The role of Dickkopf-1 in bone development, homeostasis, and disease.
[18687985] Blood 113(3): 517-25 (2009)

Pharmacological topics of bone metabolism: the physiological function of the sympathetic nervous system in modulating bone resorption.
[18431037] J Pharmacol Sci 106(4): 542-6 (2008)

Pharmacological topics of bone metabolism: recent advances in pharmacological management of osteoporosis.
[18431035] J Pharmacol Sci 106(4): 530-5 (2008)

Bone fractures after menopause.
[20427370] Hum Reprod Update 16(6): 761-73 (2010)

Parathyroid hormone versus bisphosphonate treatment on bone mineral density in osteoporosis therapy: a meta-analysis of randomized controlled trials.
[22022584] PLoS One 6(10): e26267 (2011)

Bone loss across the menopausal transition.
[20392219] Ann N Y Acad Sci 1192(-): 66-71 (2010)

Bone turnover across the menopause transition : The role of gonadal inhibins.
[20392231] Ann N Y Acad Sci 1192(-): 153-60 (2010)

Osteoporosis in patients with systemic lupus erythematosus.
[19891237] Isr Med Assoc J 11(8): 486-91 (2009)

The role of DXA bone density scans in the diagnosis and treatment of osteoporosis.
[17675543] Postgrad Med J 83(982): 509-17 (2007)

Early diagnosis of osteoporosis by means of orthopantomograms and oral x-rays: a systematic review.
[21743400] Med Oral Patol Oral Cir Bucal 16(7): e905-13 (2011)

Post-transplantation osteoporosis.
[20485902] Arq Bras Endocrinol Metabol 54(2): 143-9 (2010)

Bariatric surgery and bone metabolism: a systematic review.
[20485904] Arq Bras Endocrinol Metabol 54(2): 158-63 (2010)

SERMs in the prevention and treatment of postmenopausal osteoporosis: an update.
[20485909] Arq Bras Endocrinol Metabol 54(2): 200-5 (2010)

Bisphosphonates in the treatment of metabolic bone diseases.
[20485910] Arq Bras Endocrinol Metabol 54(2): 206-12 (2010)

The use of PTH in the treatment of osteoporosis.
[20485911] Arq Bras Endocrinol Metabol 54(2): 213-9 (2010)

Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects.
[18209880] Arq Bras Endocrinol Metabol 51(8): 1404-12 (2007)

Glucocorticoid-induced osteoporosis.
[17117304] Arq Bras Endocrinol Metabol 50(4): 793-801 (2006)

Low bone mass in children and adolescents.
[17117302] Arq Bras Endocrinol Metabol 50(4): 775-82 (2006)

Anabolic skeletal therapy for osteoporosis.
[17117299] Arq Bras Endocrinol Metabol 50(4): 745-54 (2006)

Estrogen therapy for postmenopausal osteoporosis.
[17117296] Arq Bras Endocrinol Metabol 50(4): 705-19 (2006)

Redefining osteoporosis treatment: Who to treat and how long to treat.
[17117295] Arq Bras Endocrinol Metabol 50(4): 694-704 (2006)

Office practice of osteoporosis evaluation.
[17117293] Arq Bras Endocrinol Metabol 50(4): 674-84 (2006)

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.
[20940232] CMAJ 182(17): 1864-73 (2010)

Management and Treatment of Osteoporosis in Patients Receiving Long-term Glucocorticoid Treatment: Current Status of Adherence to Clinical Guidelines and Related Factors.
[22082891] Intern Med 50(22): 2793-800 (2011)

The prevention and treatment of osteoporosis: a review.
[16369451] MedGenMed 7(2): 73 (2005)

Current status of research on osteoporosis in COPD: a systematic review.
[19567604] Eur Respir J 34(1): 209-18 (2009)

Treatment of osteoporotic fractures.
[12164513] Scand J Surg 91(2): 140-6 (2002)

Invited Review: Pathogenesis of osteoporosis.
[14555675] J Appl Physiol 95(5): 2142-51 (2003)

Effects of glucocorticoids on growth and bone mineralization.
[21234507] J Pediatr (Rio J) 87(1): 4-12 (2011)

Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy.
[18046914] Clin Interv Aging 1(4): 367-75 (2006)

Role of zoledronic acid in the prevention and treatment of osteoporosis.
[21594000] Clin Interv Aging 6(-): 89-99 (2011)

Full length parathyroid hormone (1-84) in the treatment of osteoporosis in postmenopausal women.
[18044089] Clin Interv Aging 2(1): 163-74 (2007)

The osteoporotic male: overlooked and undermanaged?
[18044181] Clin Interv Aging 2(3): 305-12 (2007)

Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment.
[19281056] Clin Interv Aging 3(4): 635-45 (2008)

Glucocorticoid-induced osteoporosis in rheumatic diseases.
[21243296] Clinics (Sao Paulo) 65(11): 1197-205 (2010)

Bone disease and idiopathic hypercalciuria.
[18359394] Semin Nephrol 28(2): 133-42 (2008)

Bone loss in inflammatory disorders.
[19443863] J Endocrinol 201(3): 309-20 (2009)

Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates.
[22087064] Drug Des Devel Ther 5(-): 445-54 (2011)

Zoledronic acid: clinical utility and patient considerations in osteoporosis and low bone mass.
[21151620] Drug Des Devel Ther 4(-): 321-35 (2010)

Cancer treatment-related bone loss: a review and synthesis of the literature.
[18231646] Curr Oncol 15(Suppl 1): S30-40 (2008)

Role of teriparatide in treatment of glucocorticoid-induced osteoporosis.
[21063460] Ther Clin Risk Manag 6(-): 497-503 (2010)

Combined treatment with vitamin k2 and bisphosphonate in postmenopausal women with osteoporosis.
[14584089] Yonsei Med J 44(5): 751-6 (2003)

Teriparatide (recombinant human parathyroid hormone 1-34) in postmenopausal women with osteoporosis: systematic review.
[19099162] Sao Paulo Med J 126(5): 279-84 (2008)

Advances in glucocorticoid-induced osteoporosis.
[21365209] Curr Rheumatol Rep 13(3): 233-40 (2011)

High-dose vitamin D: helpful or harmful?
[21369796] Curr Rheumatol Rep 13(3): 257-64 (2011)

Osteoporosis in children: pediatric and pediatric rheumatology perspective: a review.
[19835571] Pediatr Rheumatol Online J 7(-): 16 (2009)

Nephrolithiasis-associated bone disease: pathogenesis and treatment options.
[21124301] Kidney Int 79(4): 393-403 (2011)

Osteoporotic fractures in older adults.
[16979533] Best Pract Res Clin Rheumatol 20(4): 695-706 (2006)

Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal.
[21072291] Int J Womens Health 2(-): 1-6 (2010)

Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
[19561003] Clin Breast Cancer 9 Suppl 1(-): S18-27 (2009)

Role of dietary sodium in osteoporosis.
[16772639] J Am Coll Nutr 25(3 Suppl): 271S-276S (2006)

Management of glucocorticoid-induced osteoporosis: prevalence, and emerging treatment options.
[21701617] Drug Healthc Patient Saf 2(-): 49-59 (2010)

Transplantation osteoporosis.
[22069109] Endokrynol Pol 62(5): 472-85 (2011)

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club.
[21360219] Osteoporos Int 22(11): 2769-88 (2011)

The impact of pharmacist interventions on osteoporosis management: a systematic review.
[21720894] Osteoporos Int 22(10): 2587-96 (2011)

Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover.
[19436941] Osteoporos Int 21(2): 233-41 (2010)

Optimal use of vitamin D when treating osteoporosis.
[21113692] Curr Osteoporos Rep 9(1): 36-42 (2011)

Correlation of obesity and osteoporosis: effect of fat mass on the determination of osteoporosis.
[17784844] J Bone Miner Res 23(1): 17-29 (2008)

The evidence for efficacy of osteoporosis treatment in men with primary osteoporosis: a systematic review and meta-analysis of antiresorptive and anabolic treatment in men.
[21776371] J Osteoporos 2011(-): 259818 (2011)

Combination and sequential therapy with PTH and bisphosphonates.
[15758282] J Musculoskelet Neuronal Interact 4(4): 407 (2004)

Intravenous bisphosphonates for postmenopausal osteoporosis.
[21526078] J Res Med Sci 15(3): 175-84 (2010)

Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
[21147884] J Clin Endocrinol Metab 96(2): 308-19 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Osteoporosis.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Osteoporosis.php on line 92